Neuropeptide Y receptor Y5
From Wikipedia, the free encyclopedia
Neuropeptide Y receptor Y5
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | NPY5R; NPYR5 | |||||||||||||
External IDs | OMIM: 602001 MGI: 108082 HomoloGene: 21241 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 4889 | 18168 | ||||||||||||
Ensembl | ENSG00000164129 | ENSMUSG00000044014 | ||||||||||||
Uniprot | Q15761 | Q543U8 | ||||||||||||
Refseq | NM_006174 (mRNA) NP_006165 (protein) |
NM_016708 (mRNA) NP_057917 (protein) |
||||||||||||
Location | Chr 4: 164.48 - 164.49 Mb | Chr 8: 69.61 - 69.62 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Neuropeptide Y receptor Y5, also known as NPY5R, is a human gene.[1]
[edit] See also
[edit] References
[edit] Further reading
- Parker E, Van Heek M, Stamford A (2002). "Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.". Eur. J. Pharmacol. 440 (2-3): 173–87. PMID 12007534.
- Gerald C, Walker MW, Criscione L, et al. (1996). "A receptor subtype involved in neuropeptide-Y-induced food intake.". Nature 382 (6587): 168–71. doi: . PMID 8700207.
- Hu Y, Bloomquist BT, Cornfield LJ, et al. (1996). "Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior.". J. Biol. Chem. 271 (42): 26315–9. PMID 8824284.
- Herzog H, Darby K, Ball H, et al. (1997). "Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation.". Genomics 41 (3): 315–9. doi: . PMID 9169127.
- Lutz CM, Richards JE, Scott KL, et al. (1998). "Neuropeptide Y receptor genes mapped in human and mouse: receptors with high affinity for pancreatic polypeptide are not clustered with receptors specific for neuropeptide Y and peptide YY.". Genomics 46 (2): 287–90. doi: . PMID 9417917.
- Nichol KA, Morey A, Couzens MH, et al. (1999). "Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.". J. Neurosci. 19 (23): 10295–304. PMID 10575027.
- Rodriguez M, Audinot V, Dromaint S, et al. (2003). "Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.". Biochem. J. 369 (Pt 3): 667–73. doi: . PMID 12398768.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Berglund MM, Schober DA, Statnick MA, et al. (2003). "The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction.". J. Pharmacol. Exp. Ther. 306 (1): 147–56. doi: . PMID 12665544.
- Beauverger P, Rodriguez M, Nicolas JP, et al. (2005). "Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.". Cell. Signal. 17 (4): 489–96. doi: . PMID 15601626.
- Movafagh S, Hobson JP, Spiegel S, et al. (2006). "Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.". FASEB J. 20 (11): 1924–6. doi: . PMID 16891622.
- Coletta DK, Schneider J, Stern MP, et al. (2007). "Association of neuropeptide Y receptor Y5 polymorphisms with dyslipidemia in Mexican Americans.". Obesity (Silver Spring, Md.) 15 (4): 809–15. PMID 17426313.